A western blot analysis revealed the significant increase of p53 protein levels in drug-treated cancer cells, as well as the upregulation of the protein expression of p63 and p73 (measured for complexes 27 and 28) or p21 and p15 (measured for complex 26). Here, CDKN1A is linked to cancer.